Simplex Trading, LLC Ambrx Biopharma Inc. Transaction History

Simplex Trading, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 01, 2023	BUY	$9.3 - $16.6 $575,828 - $1.03 Million	61,917 Added 933.33%	68,551 $788,000
Q2 2023 Aug 04, 2023	SELL	$7.66 - $16.46 $869,946 - $1.87 Million	-113,570 Reduced 94.48%	6,634 $109,000
Q1 2023 Apr 27, 2023	BUY	$1.46 - $12.54 $159,372 - $1.37 Million	109,159 Added 988.31%	120,204 $1.07 Million
Q4 2022 Feb 02, 2023	BUY	$0.41 - $4.54 $4,528 - $50,144	11,045 New	11,045 $25,000

31.2K

Ticker AMAM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,618,400
Market Cap $1.08B
Description
Ambrx Biopharma Inc., a clinical-stage biologics company, discovers and develops engineered precision biologics using its proprietary expanded genetic code technology platform. Its lead product candidate is ARX788, an anti-HER2 antibody-drug conjugate (ADC), which is investigated in various clinical trials for the treatment of breast cancer, gas...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.